BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Sigma-Tau Pharmaceuticals To Conduct Phase II Clinical Trial In Europe With TB4 For Venous Stasis Ulcers; Pharmaceutical Firm Accelerates Phase II Commitment


10/19/2005 5:08:50 PM

RegeneRx Biopharmaceuticals, Inc. (OTCBB:RGRX) (www.regenerx.com) announced today that its strategic partner, Sigma-Tau Group (Sigma-Tau), is planning to conduct a Phase II clinical trial in Europe in the 4th quarter of 2004 to test Thymosin beta 4 (TB4) for the treatment of patients with venous stasis ulcers. The trial will be in addition to RegeneRx's planned Phase II trials in the U.S for the treatment of chronic pressure ulcers, epidermolysis bullosa, and other chronic dermal indications. In January 2004, RegeneRx exclusively licensed certain rights to TB4 to a wholly owned subsidiary within Sigma-Tau Group for the treatment of internal and external wound healing in Europe and other contiguous and geographically relevant countries.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES